1 |
任之栋,张 巧,张玉江,等. 慢性阻塞性肺疾病合并慢性肺曲霉菌病的高危因素及临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(1): 11-16.
|
2 |
Bassetti M, Garnacho-Montero J, Calandra T, et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients[J]. Intensive Care Med,2017, 43: 1225-1238.
|
3 |
Paramythiotou E, Frantzeskaki F, Flevari A, et al. Invasive fungal infections in the ICU: how to approach, how to treat[J]. Molecules, 2014, 19: 1085-1119.
|
4 |
Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients[J]. Intensive Care Med, 2007, 33: 1694-1703.
|
5 |
Denning DW. Global incidence and mortality of severe fungal disease[J]. Lancet Infect Dis, 2024: S1473-3099(24)00103-8.
|
6 |
Ao Z, Xu H, Li M, et al. Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients[J]. BMJ Open Respir Res, 2023, 10(1): e001358.
|
7 |
Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery[J]. J Clin Oncol, 1997, 15(1): 139-147.
|
8 |
Salzer HJ, Cornely OA. Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis[J]. Eur Respir J, 2017,49(2): 1602520.
|
9 |
Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis[J]. Clin Infect Dis, 2008, 47(9): 1176-1184.
|
10 |
Bulpa P, Duplaquet F, Dimopoulos G, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations[J]. Semin Respir Crit Care Med, 2020, 41(6): 851-861.
|
11 |
Chotirmall SH, Martin-Gomez MT. Aspergillus species in bronchiectasis:Challenges in the cystic fibrosis and non-cystic fibrosis airways[J]. Mycopathologia, 2018, 183(1): 45-59.
|
12 |
Tudesq JJ, Peyrony O, Lemiale V, et al. Invasive pulmonary aspergillosis in nonimmunocompromised hosts[J]. Semin Respir Crit Care Med, 2019, 40(4): 540-547.
|
13 |
Bouza E, Guinea J, Pelaez T, et al. Workload due to aspergillus fumigatus and signifcance of the organism in the microbiology laboratory of a general hospital[J]. J Clin Microbiol, 2005, 43(5): 2075-2079.
|
14 |
Fontana L, Perlin DS, Zhao Y, et al. Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic cell transplant recipients[J]. Clin Infect Dis, 2020 , 70(5): 723-730.
|
15 |
Godoy MCB, Ferreira Dalla Pria HR, Truong MT,et al. Invasive fungal pneumonia in immunocompromised patients[J]. Radiol Clin North Am, 2022, 60(3): 497-506.
|
16 |
Dandachi D, Wilson Dib R, Fernández-Cruz A, et al. Invasive pulmonary aspergillosis in patients with solid tumours: Risk factors and predictors of clinical outcomes[J]. Ann Med, 2018, 50(8): 713-720.
|
17 |
Lao M, Li C, Li J, et al. Opportunistic invasive fungal disease in patients with type 2 diabetes mellitus from Southern China: Clinical features and associated factors[J]. J Diabetes Investig, 2020, 11(3): 731-744.
|
18 |
Feng C, Zhang M, Zhang S, et al. Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice[J]. BMC Pulm Med, 2021, 21(1): 31.
|
19 |
Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study[J]. Lancet Respir Med, 2018, 6(10): 782-792.
|
20 |
Blot S, Rello J, Koulenti D. Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together[J]. Curr Opin Crit Care, 2019, 25(5): 430-437.
|
21 |
陈 虎,陈 亮,杨 健,等. 免疫正常宿主侵袭性气管支气管曲霉病一例[J]. 中国呼吸与危重监护杂志,2019, 18(6): 581-583.
|
22 |
Otu A, Kosmidis C, Mathioudakis AG, et al. The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease[J]. Infection, 2023, 51(4): 813-829.
|
23 |
Zhong H, Wang Y, Gu Y, et al. Clinical features, diagnostic test performance, and prognosis in different subtypes of chronic pulmonary aspergillosis[J]. Front Med (Lausanne), 2022, 9: 811807.
|
24 |
Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease:Clinical review of an under-recognised global challenge[J]. Respiration, 2021, 100(8): 751-763.
|
25 |
Pakpoom P, Methee C. Chronic pulmonary aspergillosis following nontuberculous mycobacterial infections: An emerging disease[J]. J Fungi (Basel), 2020, 6(4): 346.
|
26 |
胡 群,卓惠长,徐礼裕,等. 吸入糖皮质激素致侵袭性肺曲霉病一例[J]. 中华结核和呼吸杂志,2016, 39(6): 480-481.
|
27 |
Raju S, Ghosh S, Mehta AC. Chest CT signs in pulmonary disease: A pictorial review[J]. Chest, 2017, 151(6): 1356-1374.
|
28 |
Caillot D, Mannone L, Cuisenier B, et al. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients[J]. Clin Microbiol Infect, 2001, 7(Suppl 2): 54-61.
|
29 |
Bulpa P, Bihin B, Dimopoulos G, et al. Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD?[J]. Eur Respir J, 2017, 50(3): 1700532.
|
30 |
Guinea J, Torres-Narbona M, Gijon P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome[J]. Clin Microbiol Infect, 2010, 16(7): 870-877.
|